
BIOVECTRA
BIOVECTRA is a North American contract development and manufacturing organization (CDMO) specializing in clinical-to-commercial scale production capabilities for biologics, synthetic small molecules, pDNA and mRNA, highly potent active pharmaceutical ingredients (APIs) and bioreagents. They thrive on the vexing challenges few CDMOs would have the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of their organization.
Latest BIOVECTRA Content

Innovations in Biopharma 2025

A Bright Future for RNA Therapeutics

Manufacturing High Quality and Purity Antibody–Drug Conjugates

Optimizing mRNA Manufacturing: Overcoming Supply Chain Challenges With CDMO Solutions

Cell Therapy: Clinical Applications, Manufacturing and Regulation

Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies
